Stephen Mitchener

Sr VP, Chief Business Officer, Axcella Health (United States).

Companies

Karyopharm Therapeutics Inc.SVP, Chief Business Officer Jan 5, 2021 to Mar 2, 2023¹
Axcella Health (United States)Sr VP, Chief Business Officer May 8, 2019 to Dec 20, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Karyopharm Therapeutics Inc. KPTI128,313 shares³$44.7K at $0.35Mar 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2023Sold 6,357 shares at $3.03 of Karyopharm Therapeutics Inc.³
Feb 28, 2023Granted 60,000 shares of Karyopharm Therapeutics Inc.³
Aug 31, 2022Granted 20,000 shares of Karyopharm Therapeutics Inc.⁴
Feb 28, 2022Granted 47,250 shares of Karyopharm Therapeutics Inc.⁵
Dec 2, 2021Sold 499 shares at $6.69 of Karyopharm Therapeutics Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKaryopharm Therapeutics Inc., SVP, Chief Business Officer
2
SEC EDGARAxcella Health (United States), Sr VP, Chief Business Officer
3
SEC EDGARKaryopharm Therapeutics Inc. shares after the filing of Mar 1, 2023
4
SEC EDGARForm 4 filed Sep 1, 2022
5
SEC EDGARForm 4 filed Mar 2, 2022
6
SEC EDGARForm 4 filed Dec 3, 2021